NIR-II nanoprobes in-vivo assembly to improve image-guided surgery for metastatic ovarian cancer

Peiyuan Wang, Yong Fan, Lingfei Lu, Lu Liu, Lingling Fan, Mengyao Zhao, Yang Xie, Congjian Xu, Fan Zhang

Nature Communications · 2018 · 448 citations · 49 references

DOIFull text

Open access

Concepts

TL;DR

Local recurrence is a common cause of treatment failure in solid tumors, and tumor‑specific intraoperative fluorescence imaging may improve staging and debulking during cytoreductive surgery, potentially enhancing prognosis. The study reports in vivo assembly of DNA‑ and peptide‑modified NIR‑II emitting downconversion nanoparticles to enhance image‑guided surgery for metastatic ovarian cancer. The authors assembled these functionalized NIR‑II downconversion nanoparticles in vivo to serve as imaging probes. The NIR‑II DCNPs demonstrated superior imaging quality compared to ICG, with good photostability, 8‑mm tissue penetration, 6‑hour tumor retention, a high tumor‑to‑normal ratio, enabling complete excision of metastases ≤1 mm and providing a platform for future nanomaterial design.

Abstract

Local recurrence is a common cause of treatment failure for patients with solid tumors. Tumor-specific intraoperative fluorescence imaging may improve staging and debulking efforts in cytoreductive surgery and, thereby improve prognosis. Here, we report in vivo assembly of the second near-infrared window (NIR-II) emitting downconversion nanoparticles (DCNPs) modified with DNA and targeting peptides to improve the image-guided surgery for metastatic ovarian cancer. The NIR-II imaging quality with DCNPs is superior to that of clinically approved ICG with good photostability and deep tissue penetration (8 mm). Stable tumor retention period experienced 6 h by in vivo assembly of nanoprobes can be used for precise tumor resection. Superior tumor-to-normal tissue ratio is successfully achieved to facilitate the abdominal ovarian metastases surgical delineation. Metastases with ≤1 mm can be completely excised under NIR-II bioimaging guidance. This novel technology provides a general new basis for the future design of nanomaterials for medical applications.

References

49